Sigachi Industries gains on venturing into human nutritional segment
Alongside pharma, the company will be now expanding its horizon by exploring nutritional markets in India and across 45 countries, where it currently exports
Sigachi Industries is currently trading at Rs. 277.90, up by 1.90 points or 0.69% from its previous closing of Rs. 276.00 on the BSE.
The scrip opened at Rs. 277.60 and has touched a high and low of Rs. 285.00 and Rs. 275.00 respectively. So far 14185 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 648.00 on 17-Nov-2021 and a 52 week low of Rs. 231.30 on 21-Jun-2022.
Last one week high and low of the scrip stood at Rs. 289.00 and Rs. 248.10 respectively. The current market cap of the company is Rs. 854.95 crore.
The promoters holding in the company stood at 48.48%, while Institutions and Non-Institutions held 3.15% and 48.37% respectively.
Sigachi Industries has ventured into the human nutritional segment, with a prime focus on B2B markets, in India and across the globe. The company is driving the Indian growth story in the microcrystalline cellulose category with its continuous focus on innovation and quality within the industry. Alongside pharma, the company will be now expanding its horizon by exploring nutritional markets in India and across 45 countries, where it currently exports.
The product portfolio will widely incorporate spray-dried ingredients, micronutrient premixes, encapsulated ingredients, granulated ingredients, and triturates. With these ingredients, the company is looking to deepen its relationship with its current customers in Nutraceuticals, Bakery, Dairy, Infant and Medical Nutrition, Confectionery, Savoury and Snacks, and Beverages sectors.
Sigachi Industries is an industry leader in the field of Pharma Excipients, Nutra and food ingredients. The company has rapidly established itself as one of the largest manufacturers of Microcrystalline Cellulose worldwide.